Three‐year survival of transcatheter versus surgical aortic valve replacement in dialysis

To highlight the trends of surgical (open) aortic valve replacement (SAVR) as well as to compare the outcome between transcatheter aortic valve replacement (TAVR) and SAVR in elderly dialysis patients. TAVR has evolved as an effective alternative to surgery (SAVR) for aortic stenosis. We identified...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular interventions 2022-03, Vol.99 (4), p.1206-1213
Main Authors: Ogami, Takuya, Kurlansky, Paul, Takayama, Hiroo, Ning, Yuming, Zimmermann, Eric, Zhu, Roger C., Ali, Ziad A., Nazif, Tamim M., Vahl, Torsten P., Avgerinos, Dimitrios V., Smith, Craig R., Leon, Martin B., Kodali, Susheel K., George, Isaac
Format: Article
Language:English
Subjects:
Aged
Aortic stenosis
Aortic valve
Aortic Valve - diagnostic imaging
Aortic Valve - surgery
Aortic Valve Stenosis - diagnostic imaging
Aortic Valve Stenosis - etiology
Aortic Valve Stenosis - surgery
Cardiovascular disease
Congestive heart failure
Coronary artery
Coronary artery disease
Dialysis
end stage renal disease
Heart Valve Prosthesis Implantation - adverse effects
Hemodialysis
Humans
Kidney diseases
Mortality
Patients
Renal Dialysis - adverse effects
Rheumatic heart disease
Risk Factors
surgical valve replacement
Survival
TAVR
Transcatheter Aortic Valve Replacement - adverse effects
Treatment Outcome
United States - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To highlight the trends of surgical (open) aortic valve replacement (SAVR) as well as to compare the outcome between transcatheter aortic valve replacement (TAVR) and SAVR in elderly dialysis patients. TAVR has evolved as an effective alternative to surgery (SAVR) for aortic stenosis. We identified dialysis‐dependent patients who underwent SAVR or TAVR from 2000 to 2015 from the United States Renal Data System using ICD‐9 codes. We defined high‐risk surgical patients as age over 70 or older. The primary endpoint was survival at 3 years and we compared the outcome between SAVR and TAVR groups using inverse probability of treatment weighting (IPTW). A total of 4332 and 1280 dialysis patients underwent SAVR and TAVR, respectively, during the study period. Among SAVR cohort, 3312 patients underwent SAVR before June 2012 and 1020 after June 2012. In‐hospital mortality was significantly worse before 2012 (14.6% vs. 11.3% after 2012, p = 0.007) as well as estimated 3‐year mortality (69.1% vs. 60.3% after 2012, p 
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.30045